Literature DB >> 2251338

Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming.

S A Parashos1, C Marin, P Barone, V Kapitzoglou-Logothetis, T N Chase.   

Abstract

The effects of chronic D-1 and/or D-2 dopamine (DA) receptor blockade on a putative D-1 DA receptor-mediated behavioral function was studied in rats treated for 21 days with the selective D-1 antagonist SCH 23390, the predominantly D-2 antagonist haloperidol, or the combination of both drugs at the same daily doses. Four days after the last drug dose, the non-stereotyped grooming response to the selective D-1 agonist SKF 38393 increased in SCH 23390-pretreated rats decreased in haloperidol-pretreated rats compared to controls, but remained unchanged in animals receiving both drugs. Underlying DA receptor changes and the resulting imbalance between D-1 and D-2 receptor presumably contribute to these effects, suggesting that the upregulation of one DA receptor subtype may modify the expression of behaviors associated with the other subtype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251338     DOI: 10.1007/bf02244112

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

Authors:  M L Porceddu; E Ongini; G Biggio
Journal:  Eur J Pharmacol       Date:  1985-12-03       Impact factor: 4.432

4.  Neuroleptic and non-neuroleptic catalepsy.

Authors:  B Costall; R J Naylor
Journal:  Arzneimittelforschung       Date:  1973-05

5.  Quantification of R-(+)-7-chloro-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-methyl-3- benzazepine in brain and blood by use of reversed-phase high-performance liquid chromatography with electrochemical detection.

Authors:  C D Kilts; K L Dew; T D Ely; R B Mailman
Journal:  J Chromatogr       Date:  1985-08-09

6.  Induction of oral dyskinesias in naive rats by D1 stimulation.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1983-12-19       Impact factor: 5.037

7.  Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.

Authors:  A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade.

Authors:  S A Parashos; P Barone; I Tucci; T N Chase
Journal:  Life Sci       Date:  1987-11-16       Impact factor: 5.037

9.  Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.

Authors:  E J Hess; L J Albers; H Le; I Creese
Journal:  J Pharmacol Exp Ther       Date:  1986-09       Impact factor: 4.030

10.  Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

Authors:  H Rosengarten; J W Schweitzer; A J Friedhoff
Journal:  Life Sci       Date:  1986-07-07       Impact factor: 5.037

View more
  5 in total

1.  Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome.

Authors:  Jennifer L Taylor; Abha K Rajbhandari; Kent C Berridge; J Wayne Aldridge
Journal:  Brain Res       Date:  2010-01-28       Impact factor: 3.252

2.  Effects of risperidone on dopamine receptor subtypes in developing rat brain.

Authors:  Taylor Moran-Gates; Christopher Grady; Young Shik Park; Ross J Baldessarini; Frank I Tarazi
Journal:  Eur Neuropsychopharmacol       Date:  2006-12-18       Impact factor: 4.600

Review 3.  Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.

Authors:  A R Braun; M Laruelle; M M Mouradian
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Effects of kappa receptor agonists on D1 and D2 dopamine agonist and antagonist-induced behaviors.

Authors:  C Marin; T M Engber; P Chaudhuri; A Peppe; T N Chase
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

5.  Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.

Authors:  Frank I Tarazi; Taylor Moran-Gates; Erik H F Wong; Brian Henry; Mohammed Shahid
Journal:  Psychopharmacology (Berl)       Date:  2008-02-24       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.